Prostate Cancer - Results from #20780

Benefits, outcomes and limitations of active surveillance for prostate cancer May 17, 2014

Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer - Abstract May 16, 2014

The epidemiology and clinical implications of genetic variation in prostate cancer - Abstract May 16, 2014

What do the screening trials really tell us and where do we go from here? - Abstract May 16, 2014

Evolution and immediate future of US screening guidelines - Abstract May 16, 2014

Optimization of prostate biopsy: Review of technique and complications - Abstract May 16, 2014

Incidental prostate cancer at the time of cystectomy: The incidence and clinicopathological features in Chinese patients - Abstract May 16, 2014

Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged less than 70 and >= 70 years May 16, 2014

Dual optimization based prostate zonal segmentation in 3D MR images - Abstract May 15, 2014

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: Evaluation of shortening of treatment period to 3 weeks - Abstract May 15, 2014

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men - Abstract May 15, 2014

Clinical presentation of prostate cancer in Black South Africans - Abstract May 15, 2014

A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapy - Abstract May 15, 2014

Transurethral resection of the prostate after radiotherapy for prostate cancer: Impact on quality of life - Abstract May 15, 2014

Cancer stem cells in prostate cancer chemoresistance - Abstract May 15, 2014

Prostate-specific antigen flare induced by cabazitaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer - Abstract May 15, 2014

Dendreon announces presentation of PROVENGE® (sipuleucel-T) and DN24-02 immuno-oncology data at the 2014 ASCO Annual Meeting May 15, 2014

Myriad strengthens commitment to cancer research at the ASCO 50th Annual Meeting May 15, 2014

Time trends in prostate cancer mortality according to major geographic regions of Brazil: An analysis of three decades - Abstract May 15, 2014

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors - Abstract May 15, 2014

Page 1040 of 1447